AI in Cell Therapy: Dr. Geoffrey Stephens on Biotech Innovation

In this episode, we welcome Dr. Geoffrey Stephens, a visionary in biotechnology with over 20 years of experience in drug development and advanced therapies. We'll explore his journey from the NIH to leading innovative projects at AiCella, where AI meets cell therapy, revolutionizing treatments for diseases like cancer and asthma. Dr. Stephens will share groundbreaking insights into how AiCella utilizes artificial intelligence to optimize cell therapy processes, opening new avenues for personalized medicine. Additionally, we delve into the significance of developing CAR-T and TCR-T therapies, emphasizing their potential impact in the fight against cancer and autoimmune diseases. Join us for insights on overcoming challenges in biotechnology and advice on leadership in the scientific community.